Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide. 

Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release. 

In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers’ needs, based on profound experience with EU and FDA regulations. 

Cellex also stands for a successful tech transfer of processes from US to Europe. 

Our apheresis center is specialized in collections of different starting materials from healthy and diseased donors. Cellex runs its own highly diverse donor pool and offers fresh leukopaks, mobilized cells, bone marrow or whole blood products customized for R&D, clinical or commercial purposes. 

IT and transport solutions complete the Cellex portfolio.